Pivhydrazine
Clinical data
Other namesAngorvid, Betamezid, Neomarsilid, Pivazide, Pivhydrazine
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • N'-benzyl-2,2-dimethyl-propanehydrazide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.005.620 Edit this at Wikidata
Chemical and physical data
FormulaC12H18N2O
Molar mass206.289 g·mol−1
  • InChI=1S/C12H18N2O/c1-12(2,3)11(15)14-13-9-10-7-5-4-6-8-10/h4-8,13H,9H2,1-3H3,(H,14,15) checkY
  • Key:FWWDFDMCZLOXQI-UHFFFAOYSA-N checkY
  (verify)

Pivhydrazine (trade name Tersavid), also known as pivalylbenzhydrazine and pivazide, is an irreversible and non-selective monoamine oxidase inhibitor (MAOI) of the hydrazine family. It was formerly used as an antidepressant in the 1960s, but has since been discontinued.[1][2][3]

See also

References

  1. ^ Herman ZS, Sokola A, Lenartowicz H, Zieliński M, Depta L (May–June 1976). "The influence of antidepressive drugs on the level of acetylcholine and on the acetylcholinesterase activity in the brain of rats". Polish Journal of Pharmacology and Pharmacy. 28 (4): 313–21. OCLC 1586290. PMID 981020.
  2. ^ Bolton GC, Griffiths LA (November–December 1979). "The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat". Drug Metabolism and Disposition. 7 (6): 388–92. OCLC 1784380. PMID 43225.
  3. ^ Mikhaĭlova TV, Gilev AP, Khavronina-Gureeva ZP (1969). "[Central effects of betamezide]". Farmakologiia I Toksikologiia (in Russian). 32 (6): 652–6. OCLC 1568906. PMID 5381593.
Categories